Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact - Wikidata - awgldk - TriplyDB

Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact

Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact

http://www.wikidata.org/entity/Q58070877

about

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia.Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Approach to managing behavioural disturbances in dementia.Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study Comparative safety of antipsychotic medications in nursing home residents The association between multimorbidity and hospitalization is modified by individual demographics and physician continuity of care: a retrospective cohort study.The impact of European regulatory policies on psychotropic drug prescribing patterns.Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities.Nursing home prices and quality of care - Evidence from administrative data.A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use.A 3-year study of high-cost users of health care Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.Variation in Emergency Department Transfer Rates from Nursing Homes in Ontario, Canada.Prescribing for older people in nursing homes: a review of the key issues.Quality measures for medication continuity in long-term care facilities, using a structured panel process.Off-label prescribing in older patients.Aripiprazole in the treatment of Alzheimer's disease.Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls.Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.Antipsychotic medication dispensing and associated odds ratios of death in elderly veterans and war widows, 2001.Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.Geriatric drug utilisation of psychotropics in Belgian nursing homes.Barriers to antipsychotic discontinuation in nursing homes: an exploratory study.Use of major and minor tranquilizers with older patients in an acute care hospital: an exploratory study.The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics.

P2860

Q33203719-9976C20F-068F-46D4-8C4F-0DD89343C7A8 Q33536593-9A0CCEB5-00A3-450F-9C59-56D085271310 Q33976565-67358D64-37F7-47B2-BEED-AC27C5AA6CC6 Q34571959-93559909-EDD9-4A6A-B198-CFA9648A2CCA Q34683770-EA071292-610D-47A9-BABC-E82D62AFC00F Q35627432-92A6F30B-5F9F-4E8F-879F-DBA8C68B324A Q35775454-91A0822A-0020-4736-9D83-7E94313C555C Q35828059-4B6F4D3B-898C-42E9-BB38-B5F3DB534B86 Q36001324-3C714F13-60A6-4048-94DE-93C033C975B2 Q36272515-657F9C17-9FFB-483A-A16B-78E79AB43B67 Q36360262-6AD78F32-51EC-4F6A-AB3B-314445ADEB7B Q36373744-9AD9F3F1-9DC6-423D-8DEE-712801F1206E Q36389719-BB28C19F-4897-4CFB-979B-FFDC1C50643B Q36581833-99C418C4-E46B-469E-A40A-6EFD59B47E28 Q37166113-8C15017F-C999-41DB-B0BB-CF1B2F0FD3C2 Q37573568-3BBDCBF3-AEC6-4A6F-801D-1B7115BDB4DB Q37837997-CB57D115-0A8B-4AF6-8EDB-3D4A9658A6EC Q37998512-630E7117-25DD-45FC-A1ED-B83D4D98CF12 Q38014122-24385023-5D6D-45B5-B600-BAFC2A005770 Q38076765-B0A62F3F-BA35-494F-BA87-2CFF698C713E Q38152394-4DECA058-1BB8-424E-A75A-6BBB004ACC82 Q38182842-3F604CF9-25DE-470F-ABB4-0B680C81EAF8 Q45332573-E2DB47A0-11BB-43F3-96FD-834B71C35BB7 Q46100895-29D038AF-C407-4949-BBD7-CB1CFB5DC87F Q48312802-28175158-C13B-45F0-8B6B-C20719CA0D8C Q49113515-4481BB4E-FC45-42F7-855A-AB40FCE669C3 Q50106710-3FE457BA-62F8-4A08-A38B-658A44E2C3B2 Q51867401-9EDF95A3-4172-4E9D-B9FB-BE95744E3D54

P2860

Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact

http://www.wikidata.org/entity/Q58070877

description

im Mai 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 May 2004

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2004

@uk

name

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@en

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@nl

type

label

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@en

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@nl

prefLabel

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@en

Neuroleptic Drug Therapy in Ol ...... , Dose, and Specialist Contact

@nl

P1433

Q58070877-884127BC-25A6-4760-A31D-A4FB431D3FAA

P1476

Q58070877-69C9FDE7-3277-4C25-9E12-BA1EFF197B0C

P2093

Q58070877-2E863497-12FD-488B-8C82-A404C9EBA258

Q58070877-B7A2ED5F-A54A-4370-B214-5120B24E5547

Q58070877-BBAB4B2D-F5A0-437A-A213-FFA5685CC5E7

Q58070877-D8C028D2-9CCA-417C-8039-3E479408C7F0

Q58070877-E6CB9E60-E820-4E86-A5CE-1779FFBF63F2

Q58070877-F2D4902F-6AA9-44E1-8423-5D9D13B234FA

P2860

Q58070877-32920169-B91B-4B89-BEC9-BCC5693BBD7B

Q58070877-447CD055-34A5-41D5-AB87-D03B4AFE0B84

Q58070877-44974745-83B8-427E-B901-4675090472A0

Q58070877-50B668A3-15B7-45BF-BAD7-08F8C06398EC

Q58070877-5E47A958-A510-4775-BD6D-3435FF870C8A

Q58070877-923C0FED-BC61-447E-803B-6B9E14D3A2ED

Q58070877-BC6FE032-FB84-4B3E-9076-646C8ECA1DFC

Q58070877-BE3B6DDB-0909-42D0-B333-78AF29CD8361

Q58070877-C41A2729-AA92-4E1F-91F2-627089DE45D3

Q58070877-FA4A024C-8086-49DA-8D1B-93B5F85131C3

P304

Q58070877-0E850982-F009-4D9E-A35F-05F9403FDE33

P31

Q58070877-41982BAD-AB13-4BCA-BA76-6B80F980DB5D

P356

Q58070877-003C268E-FFA2-4C03-8F68-A1CABCAB048E

P407

Q58070877-7F55EFEC-37B7-4C39-85C8-11E8A2C90F5D

P433

Q58070877-FCC2A8A0-7EB7-458E-A540-3E7DC2D33CEE

P478

Q58070877-6677527A-D673-4B63-9182-3528A09B5692

P50

Q58070877-1FDCECEB-CB4E-495B-9719-9602CD49DB71

P577

Q58070877-D1DBAF88-DF5B-45DF-9887-90D1144EA0D4

P698

Q58070877-55E59E32-9B35-4B4A-B37A-27998951B77C

P356

J.1532-5415.2004.52212.X

P1433

Journal of the American Geriatrics Society

P1476

Neuroleptic drug therapy in ol ...... , dose, and specialist contact

@en

P2093

Geoffrey M Anderson

http://www.w3.org/2001/XMLSchema#string

Kathy Sykora

http://www.w3.org/2001/XMLSchema#string

Kenneth I Shulman

http://www.w3.org/2001/XMLSchema#string

Sudeep Gill

http://www.w3.org/2001/XMLSchema#string

Susan E Bronskill

http://www.w3.org/2001/XMLSchema#string

Walter P Wodchis

http://www.w3.org/2001/XMLSchema#string

P2860

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Recommendations for the management of behavioral and psychological symptoms of dementia.

A metaanalysis of controlled trials of neuroleptic treatment in dementia.

Improving medication prescribing and utilization in the nursing home.

Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents.

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

Survey of neuroleptic prescribing in residents of nursing homes in Glasgow.

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.

Characteristics and quality of prescribing by doctors practicing in nursing homes.

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

P304

749-755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1532-5415.2004.52212.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15086656

http://www.w3.org/2001/XMLSchema#string